Sreelatha Chalasani, MD
Rheumatology · Rock Hill, SCNPI 1063618080
Payments from drug & device makers
Across 540 payments — averaging $19.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- AbbVie$1K
- Johnson & Johnson$1K
- AstraZeneca$901
- Pfizer$861
- UCB, Inc.$588
- plus $3K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 170 | $2,356 |
| AbbVie | 51 | $1,191 |
| Johnson & Johnson(2 entities) | 49 | $1,161 |
| AstraZeneca(2 entities) | 39 | $901 |
| Pfizer | 45 | $861 |
| UCB, Inc. | 23 | $588 |
| Novartis | 24 | $547 |
| GSK | 21 | $526 |
| Boehringer Ingelheim | 14 | $335 |
| Lilly USA, LLC | 18 | $311 |
| E.r. Squibb & Sons, L.L.C. | 20 | $286 |
| Radius Health, Inc. | 7 | $158 |
| Mallinckrodt Hospital Products Inc. | 6 | $137 |
| Sandoz | 6 | $134 |
| Organon | 8 | $127 |
| Sanofi | 5 | $112 |
| Scilex Pharmaceuticals Inc. | 4 | $87 |
| ANI Pharmaceuticals, Inc. | 3 | $82 |
| Ultragenyx Pharmaceutical Inc. | 3 | $56 |
| Fresenius Kabi USA, LLC | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 3 | $41 |
| Bristol Myers Squibb | 2 | $39 |
| Tersera Therapeutics LLC | 2 | $38 |
| Zimmer Biomet | 1 | $37 |
| IBSA Pharma Inc. | 2 | $31 |
| Merck | 2 | $31 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $27 |
| Mallinckrodt Enterprises LLC | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Aurinia Pharma U.S., Inc. | 1 | $20 |
| Bioventus LLC | 1 | $19 |
| Nevro Corp. | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Avion Pharmaceuticals | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $12 |
| Hikma Pharmaceuticals USA | 1 | $12 |
How this compares
$10,393 in reported general payments places this provider in the 60th percentile of 123 rheumatology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Rock Hill
- James WilsonRock Hill$11K
- Clarence LegertonSummerville$7.7M
- Gary FinkSummerville$6.9M
- William EdwardsSummerville$5.9M
- Colin EdgertonSummerville$4.6M
- Gregory NiemerSummerville$4.4M
- Jennifer MurphySummerville$4.4M
- Richard SilverCharleston$1.6M
- Alan BrownGreenville$947K
- Mitchell FeinmanOrangeburg$824K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.